KALA - Kala Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KALA is currently covered by 3 analysts with an average price target of $281.4. This is a potential upside of $274.6 (4038.24%) from yesterday's end of day stock price of $6.8.

Kala Pharmaceuticals's activity chart (see below) currently has 10 price targets and 44 ratings on display. The stock rating distribution of KALA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 5.42% with an average time for these price targets to be met of 26.63 days.

Highest price target for KALA is $15, Lowest price target is $15, average price target is $281.4.

Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 15-Nov-2024. First documented stock forecast 25-Oct-2017.

Currently out of the existing stock ratings of KALA, 13 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$15

$8.2 (120.59%)

$18

9 days ago
(15-Nov-2024)

1/10 (10%)

$8.24 (121.89%)

65

Buy

$15

$8.2 (120.59%)

$15

3 months 5 days ago
(19-Aug-2024)

0/4 (0%)

$8.72 (138.85%)

Buy

$22

$15.2 (223.53%)

$47

1 years 10 days ago
(14-Nov-2023)

0/2 (0%)

$16.8 (323.08%)

Buy

2 years 3 months 9 days ago
(15-Aug-2022)

0/2 (0%)

$390 (108.33%)

Sell

$75

$68.2 (1002.94%)

2 years 7 months 25 days ago
(30-Mar-2022)

0/2 (0%)

$2 (2.74%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KALA (Kala Pharmaceuticals) average time for price targets to be met?

On average it took 26.63 days on average for the stock forecasts to be realized with a an average price target met ratio 5.42

Which analyst has the current highest performing score on KALA (Kala Pharmaceuticals) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the current lower performing score on KALA (Kala Pharmaceuticals) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on KALA (Kala Pharmaceuticals)?

Francois Brisebois works at OPPENHEIMER and has 13 price targets and 7 ratings on KALA

Which analyst is the currently most bullish on KALA (Kala Pharmaceuticals)?

Tazeen Ahmad with highest potential upside - $791.1

Which analyst is the currently most reserved on KALA (Kala Pharmaceuticals)?

Chris Schott with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?